Related references
Note: Only part of the references are listed.Identification and Validation of Novel Small Molecule Disruptors of HuR-mRNA Interaction
Xiaoqing Wu et al.
ACS CHEMICAL BIOLOGY (2015)
Human antigen R mediated post-transcriptional regulation of epithelial-mesenchymal transition related genes in diabetic nephropathy
Che Yu et al.
JOURNAL OF DIABETES (2015)
The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells
F. M. S. Gurgis et al.
ONCOGENE (2015)
Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis
Sung-Hee Chang et al.
CURRENT OPINION IN HEMATOLOGY (2014)
Hu Antigen R (HuR) Is a Positive Regulator of the RNA-binding Proteins TDP-43 and FUS/TLS IMPLICATIONS FOR AMYOTROPHIC LATERAL SCLEROSIS
Liang Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cryptotanshinone Attenuates Cardiac Fibrosis via Downregulation of COX-2, NOX-2, and NOX-4
Yunzi Ma et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Structural basis for RNA recognition in roquin-mediated post-transcriptional gene regulation
Andreas Schlundt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity
Franziska Bollmann et al.
NUCLEIC ACIDS RESEARCH (2014)
The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding
Hong Wang et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
Targeting Transmembrane TNF-α Suppresses Breast Cancer Growth
Mingxia Yu et al.
CANCER RESEARCH (2013)
Mechanisms coordinating ELAV/Hu mRNA regulons
Laura E. Simone et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Tanshinone derivatives: a patent review (January 2006-September 2012)
Xiao-Hong Tian et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Tanshinone IIA Inhibits Breast Cancer Stem Cells Growth In Vitro and In Vivo Through Attenuation of IL-6/STAT3/NF-kB Signaling Pathways
Caiyu Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis
Jing Chen et al.
JOURNAL OF IMMUNOLOGY (2013)
Autophagy Activation Clears ELAVL1/HuR-Mediated Accumulation of SQSTM1/p62 during Proteasomal Inhibition in Human Retinal Pigment Epithelial Cells
Johanna Viiri et al.
PLOS ONE (2013)
A Novel High Throughput Biochemical Assay to Evaluate the HuR Protein-RNA Complex Formation
Vito G. D'Agostino et al.
PLOS ONE (2013)
Recognition of the let-7g miRNA precursor by human Lin28B
P. Shaik Syed Ali et al.
FEBS LETTERS (2012)
TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155
Jiajie Tu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
Elisa Latorre et al.
MOLECULAR CANCER (2012)
The mRNA Stability Factor HuR Inhibits MicroRNA-16 Targeting of COX-2
Lisa E. Young et al.
MOLECULAR CANCER RESEARCH (2012)
HuR protein attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA
Pradipta Kundu et al.
NUCLEIC ACIDS RESEARCH (2012)
The p38/MK2-Driven Exchange between Tristetraprolin and HuR Regulates AU-Rich Element-Dependent Translation
Christopher Tiedje et al.
PLOS GENETICS (2012)
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Sergei I. Grivennikov et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium
T. Kurosu et al.
BRITISH JOURNAL OF CANCER (2011)
Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA Stability
Neelanjan Mukherjee et al.
MOLECULAR CELL (2011)
The PKCβ/HuR/VEGF pathway in diabetic retinopathy
M. Amadio et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes
Nadine Schmidt et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice
Prasanna Krishnamurthy et al.
FASEB JOURNAL (2010)
Functional analysis of CDKN2A/p16INK4a 5′-UTR variants predisposing to melanoma
Alessandra Bisio et al.
HUMAN MOLECULAR GENETICS (2010)
Loss of Repression of HuR Translation by miR-16 May Be Responsible for the Elevation of HuR in Human Breast Carcinoma
Fang Xu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Tumor necrosis factor blockade and the risk of viral infection
Seo Young Kim et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins
Tarnjit K. Khera et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Posttranscriptional regulation of cancer traits by HuR
Kotb Abdelmohsen et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2010)
Post-transcriptional regulons coordinate the initiation and resolution of inflammation
Paul Anderson
NATURE REVIEWS IMMUNOLOGY (2010)
Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-α mRNA
Min-Ju Chae et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Coordinated posttranscriptional mRNA population dynamics during T-cell activation
Neelanjan Mukherjee et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules
Irina Tsoy Nizamutdinova et al.
CARCINOGENESIS (2008)
Tanshinone IIA From Salvia miltiorrhiza BUNGE inhibits Human Aortic Smooth Muscle Cell Migration and MMP-9 Activity Through AKT Signaling Pathway
Un-Ho Jin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Anticancer effects of tanshinone I in human non-small cell lung cancer
Chen-Yu Lee et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR
Nicole-Claudia Meisner et al.
NATURE CHEMICAL BIOLOGY (2007)
Phosphorylation of HuR by Chk2 regulates SIRT1 expression
Kotb Abdelmohsen et al.
MOLECULAR CELL (2007)
New developments in the chemistry and biology of the bioactive constituents of Tanshen
Xihong Wang et al.
MEDICINAL RESEARCH REVIEWS (2007)
Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis
Alessandro Provenzani et al.
CARCINOGENESIS (2006)
Immunoprecipitation of mRNA-protein complexes
Tiina Peritz et al.
NATURE PROTOCOLS (2006)
The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages
FM Ho et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs
A Lal et al.
EMBO JOURNAL (2004)
A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia
WK Kim et al.
NEUROPHARMACOLOGY (2004)
Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR
ES Akool et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability
KR Mahtani et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs
M Hennecke et al.
NUCLEIC ACIDS RESEARCH (2001)
The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR
JLE Dean et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The role of 3'-' untranslated region (3 '-UTR) mediated mRNA stability in cardiovascular pathophysiology
CM Misquitta et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Share Paper
